Oral Antimicrobial Therapy: Efficacy and Safety for Methicillin-Resistant Staphylococcus aureus Infections and Its Impact on the Length of Hospital Stay.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4189139)

Published in Infect Chemother on September 24, 2014

Authors

Young Kyung Yoon1, Eu Suk Kim2, Jian Hur3, Shinwon Lee4, Shin Woo Kim5, Jin Won Cheong6, Eun Ju Choo7, Hong Bin Kim2

Author Affiliations

1: Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
2: Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
3: Division of Infectious Diseases, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea.
4: Division of Infectious Diseases, Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea.
5: Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
6: Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Medical Center, Seoul, Korea.
7: Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea.

Articles cited by this

CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03

Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43

Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med (2006) 18.83

Prosthetic-joint infections. N Engl J Med (2004) 12.71

Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07

Osteomyelitis. Lancet (2004) 6.14

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13

What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis (2008) 4.44

A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother (2007) 2.22

Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol (2004) 2.17

Bacterial septic arthritis in adults. Lancet (2010) 1.89

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med (1992) 1.69

Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2006) 1.57

Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2004) 1.46

Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis (2002) 1.21

Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. J Infect (2007) 1.10

Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infect Control Hosp Epidemiol (2009) 1.02

Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemother (2012) 1.00

Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature. Hawaii Med J (2006) 0.92

Community-associated Panton-Valentine leukocidin-negative meticillin-resistant Staphylococcus aureus clone (ST72-MRSA-IV) causing healthcare-associated pneumonia and surgical site infection in Korea. J Hosp Infect (2012) 0.92

Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs. Ann Pharmacother (2006) 0.89

Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Clin Ther (2012) 0.87

Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Clin Microbiol Infect (2014) 0.86

Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin. Mil Med (2006) 0.84

Oral antibiotic treatment of staphylococcal bone and joint infections in adults. J Antimicrob Chemother (2013) 0.81

Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK. Int J Antimicrob Agents (2008) 0.78

Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention. Curr Infect Dis Rep (2011) 0.78

First imported case of skin infection caused by PVL-positive ST30 community-associated methicillin-resistant Staphylococcus aureus clone in a returning Korean traveler from the Philippines. J Korean Med Sci (2013) 0.77